Sign up USA
Proactive Investors - Run By Investors For Investors

Q BioMed says cancer pain drug will be available later this month

The Strontium Chloride 89 (SR89) injection has been approved by the FDA ..
Q BioMed says cancer pain drug will be available later this month
A cancer cell

Q BioMed Inc (OTCMKTS:QBIO)  said it expects its cancer pain drug to be available later this month (October) and announced the launch of a website for  patients, doctors and caregivers.

The Strontium Chloride 89 (SR89) injection has been approved by the FDA and is a non-opioid injection to relieve bone pain in patients with painful skeletal metastases.

Clinical studies showed the combination of alternating weekly chemohormonal therapies with Strontium-89 demonstrated a prolonged progression-free and overall survival in patients.

The website is at  http://www.PainFreeCancer.com.

In the body, Strontium-89 acts in a similar way to calcium and is preferentially taken up in osteoblastic tissue selectively localizing in bone.

Q BioMed shares added 2.13% to US$3.83 each.

View full QBIO profile View Profile

Q BioMed Inc Timeline

Related Articles

picture of addict
November 15 2017
To build the UK's first £1bn, self-sustainable biotech is the aim for chief executive Clive Dix
Harley Street sign
December 07 2017
The injection will bankroll the continuing technical development of the firm’s first LIGHT system and its installation at the Harley Street Proton Therapy Centre
laboratory
April 12 2018
Mission is to make stem cell treatments accessible and affordable to as many people as possible
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use